Reprogramming
Welcome to MedLibrary.org. For best results, we recommend beginning with the navigation links at the top of the page, which can guide you through our collection of over 14,000 medication labels and package inserts. For additional information on other topics which are not covered by our database of medications, just enter your topic in the search box below:
Reprogramming refers to erasure and remodeling of epigenetic marks, such as DNA methylation, during mammalian development[1]. After fertilization some cells of the newly formed embryo migrate to the germinal ridge and will eventually become the germ cells (sperm and oocytes). Due to the phenomenon of genomic imprinting, maternal and paternal genomes are differentially marked and must be properly reprogrammed every time they pass through the germline. Therefore, during the process of gametogenesis the primordial germ cells must have their original biparental DNA methylation patterns erased and re-established based on the sex of the transmitting parent.
After fertilization the paternal and maternal genomes are once again demethylated and remethylated (except for differentially methylated regions associated with imprinted genes). This reprogramming is likely required for totipotency of the newly formed embryo and erasure of acquired epigenetic changes. In vitro manipulation of pre-implantation embryos has been shown to disrupt methylation patterns at imprinted loci[2] and plays a crucial role in cloned animals[3].
History
The first person to successfully demonstrate reprogramming was Sir John Gurdon, who in 1962 demonstrated that differentiated somatic cells could be reprogrammed back into an embryonic state when he managed to obtain swimming tadpoles following the transfer of differentiated intestinal epithelial cells into enucleated frog eggs[4]. For this achievement he received the 2012 Nobel Prize in Medicine alongside Shinya Yamanaka. Dr. Yamanaka was the first to demonstrate that this somatic cell nuclear transfer or oocyte-based reprogramming process (see below), that Dr. Gurdon discovered, could be recapitulated by defined factors (OCT4, SOX2, KLF4 and cMYC) to generate induced pluripotent stem cells (iPSCs).
Drs Ian Wilmut and Keith Campbell were the first to demonstrate that an adult mammalian cell could be reprogrammed back into a pluripotent state when they cloned Dolly the sheep in 1997.
Somatic cell nuclear transfer
An oocyte can reprogram an adult nucleus into an embryonic state after somatic cell nuclear transfer, so that a new organism can be developed from such cell [5] (see also: cloning)
Reprogramming is distinct from development of a somatic epitype[6], as somatic epitypes can potentially be altered after an organism has left the developmental stage of life.[7]
During somatic cell nuclear transfer, the oocyte turns off tissue specific genes in the Somatic cell nucleus and turns back on embryonic specific genes.
See also:
Induced pluripotent stem cells
References
- ^ Reik W, Dean W, Walter J (August 2001). "Epigenetic reprogramming in mammalian development" (Review). Science 293 (5532): 1089–93. doi:10.1126/science.1063443. PMID 11498579.
- ^ Mann MR, Chung YG, Nolen LD, Verona RI, Latham KE, Bartolomei MS (September 2003). "Disruption of imprinted gene methylation and expression in cloned preimplantation stage mouse embryos". Biol. Reprod. 69 (3): 902–14. doi:10.1095/biolreprod.103.017293. PMID 12748125.
- ^ Wrenzycki C, Niemann H (December 2003). "Epigenetic reprogramming in early embryonic development: effects of in-vitro production and somatic nuclear transfer" (Review). Reprod. Biomed. Online 7 (6): 649–56. PMID 14748963.
- ^ Gurdon JB (December 1962). "The developmental capacity of nuclei taken from intestinal epithelium cells of feeding tadpoles". J Embryol Exp Morphol. 10: 622–40.
- ^ Hochedlinger K, Jaenisch R (June 2006). "Nuclear reprogramming and pluripotency" (PDF). Nature 441 (7097): 1061–7. doi:10.1038/nature04955. PMID 16810240.(Review)
- ^ Lahiri DK, Maloney B (2006). "Genes are not our destiny: the somatic epitype bridges between the genotype and the phenotype". Nature Rev Neurosci. 7 (12). doi:10.1038/nrn2022-c1.
- ^ Mathers JC (June 2006). "Nutritional modulation of ageing: genomic and epigenetic approaches". Mech. Ageing Dev. 127 (6): 584–9. doi:10.1016/j.mad.2006.01.018. PMID 16513160.